Tandem Diabetes Care Inc (FRA:TD5A)
€ 46.5 -0.61 (-1.29%) Market Cap: 3.09 Bil Enterprise Value: 3.10 Bil PE Ratio: 0 PB Ratio: 13.74 GF Score: 77/100

Tandem Diabetes Care Inc at Raymond James Human Health Innovation Conference (Virtual) Transcript

Jun 17, 2020 / 05:40PM GMT
Release Date Price: €74.49 (+0.69%)
Jayson Tyler Bedford
Raymond James & Associates, Inc., Research Division - Senior Medical Supplies and Devices Analyst

Good afternoon. Welcome to the Raymond James Human Health and Innovation Conference. I'm Jayson Bedford, the medical device analyst here at Raymond James. Thanks to those on the webcast, and thanks to John, Leigh and Susan for participating and spending some time with us this afternoon, or I guess, late morning, depending on where you are. The video component of this is nice, and it's given me a great excuse to wear a long sleeve shirt without a collar, which hasn't happened in a while.

Questions & Answers

Jayson Tyler Bedford
Raymond James & Associates, Inc., Research Division - Senior Medical Supplies and Devices Analyst

So let's just get started with today's announcement. Congratulations on the approval for ages 6-plus. I hate to put you on the spot here. But when you think of the 1.6 million people with type 1 diabetes in the U.S., roughly how many are between the ages of 6 and 13? And how many are on pumps? And what

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot